NEVILLE RODIE & SHAW INC - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 1 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NEVILLE RODIE & SHAW INC ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q4 2023$250
+66.7%
1,157,3320.0%0.02%
+53.8%
Q3 2023$150
-64.0%
1,157,3320.0%0.01%
-63.9%
Q2 2023$417
-49.4%
1,157,332
-34.0%
0.04%
-52.0%
Q1 2023$824
-6.0%
1,753,5000.0%0.08%
-8.5%
Q4 2022$877
-99.9%
1,753,5000.0%0.08%
-25.5%
Q3 2022$1,115,000
-19.5%
1,753,5000.0%0.11%
-11.3%
Q2 2022$1,385,000
+9792.9%
1,753,500
+9920.0%
0.12%
+12300.0%
Q1 2022$14,000
-22.2%
17,5000.0%0.00%0.0%
Q4 2021$18,000
-21.7%
17,5000.0%0.00%
-50.0%
Q3 2021$23,000
+64.3%
17,5000.0%0.00%
+100.0%
Q2 2021$14,000
-22.2%
17,5000.0%0.00%0.0%
Q1 2021$18,000
-25.0%
17,5000.0%0.00%
-50.0%
Q4 2020$24,000
+84.6%
17,5000.0%0.00%
+100.0%
Q3 2020$13,000
-7.1%
17,5000.0%0.00%0.0%
Q2 2020$14,000
-72.5%
17,500
-50.0%
0.00%
-66.7%
Q1 2020$51,000
+27.5%
35,000
+100.0%
0.00%
-25.0%
Q4 2019$40,000
+263.6%
17,5000.0%0.00%
+300.0%
Q3 2019$11,000
-26.7%
17,5000.0%0.00%
-50.0%
Q2 2019$15,000
-21.1%
17,5000.0%0.00%0.0%
Q1 2019$19,000
+90.0%
17,5000.0%0.00%
+100.0%
Q4 2018$10,000
-37.5%
17,5000.0%0.00%
-50.0%
Q3 2018$16,000
+100.0%
17,5000.0%0.00%
+100.0%
Q2 2018$8,00017,5000.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q4 2023
NameSharesValueWeighting ↓
COURAGE CAPITAL MANAGEMENT LLC 1,000,000$804,0000.77%
Sargent Investment Group, LLC 3,643,979$2,931,0000.74%
Arkadios Wealth Advisors 1,399,000$1,125,0000.15%
Kingsbury Capital Investment Advisors LLC 119,949$96,0000.11%
JTC Employer Solutions Trustee Ltd 775,000$632,0000.07%
Platform Technology Partners 142,410$115,0000.06%
Main Street Financial Solutions, LLC 400,826$322,0000.05%
National Wealth Management Group, LLC 32,100$25,8210.02%
STALEY CAPITAL ADVISERS INC 600,000$483,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 753,391$606,0000.01%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders